83 related articles for article (PubMed ID: 2170226)
41. DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas.
Dolan JR; McCall AR; Gooneratne S; Walter S; Lansky DM
Gynecol Oncol; 1993 Feb; 48(2):232-5. PubMed ID: 8428696
[TBL] [Abstract][Full Text] [Related]
42. DNA content as prognostic factor in cervix carcinoma stage IB-III treated with radiotherapy.
Lutgens LC; Schutte B; de Jong JM; Thunnissen FB
Gynecol Oncol; 1994 Sep; 54(3):275-81. PubMed ID: 8088604
[TBL] [Abstract][Full Text] [Related]
43. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
Volm M; Drings P; Kleine W; Mattern J
Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
[TBL] [Abstract][Full Text] [Related]
44. DNA content in malignant salivary gland tumours.
Monteiro LS; Palmeira C; Bento MJ; Lopes C
Oral Dis; 2009 May; 15(4):295-301. PubMed ID: 19320959
[TBL] [Abstract][Full Text] [Related]
45. Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization.
Hudelist G; Singer CF; Kubista E; Manavi M; Mueller R; Pischinger K; Czerwenka K
Histopathology; 2004 Dec; 45(6):633-7. PubMed ID: 15569055
[TBL] [Abstract][Full Text] [Related]
46. The role of DNA flow cytometry in borderline malignant ovarian tumors.
Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM
Cancer; 1996 Aug; 78(4):794-802. PubMed ID: 8756374
[TBL] [Abstract][Full Text] [Related]
47. Computer assisted image analysis of bladder tumour nuclei for morphonuclear and ploidy assessment.
Colombel MC; Pous MF; Abbou CC; Vanvelthoven R; Bellot J; Spyratos F; Andrieu C; de Launoit Y; Chopin DK
Anal Cell Pathol; 1994 Feb; 6(2):137-47. PubMed ID: 8167096
[TBL] [Abstract][Full Text] [Related]
48. [Psammoma bodies in cytological vaginal smears in metastatic ovarian carcinoma].
Erz W; Stoll P; Schrage R
Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):229-30. PubMed ID: 7789713
[TBL] [Abstract][Full Text] [Related]
49. Psammoma bodies in serous carcinoma of the ovary. A prognostic study.
Aure JC; Hoeg K; Kolstad P
Am J Obstet Gynecol; 1971 Jan; 109(1):113-8. PubMed ID: 4321483
[No Abstract] [Full Text] [Related]
50. DNA cytometry of pure dysgerminomas of the ovary.
Oud PS; Soeters RP; Pahlplatz MM; Hermkens HG; Beck HL; Reubsaet-Veldhuizen J; Vooijs GP
Int J Gynecol Pathol; 1988; 7(3):258-67. PubMed ID: 3182171
[TBL] [Abstract][Full Text] [Related]
51. Ultrastructural studies on the morphogenesis of psammoma bodies in ovarian serous neoplasia.
Ferenczy A; Talens M; Zoghby M; Hussain SS
Cancer; 1977 Jun; 39(6):2451-9. PubMed ID: 872045
[TBL] [Abstract][Full Text] [Related]
52. Psammomabody content and DNA-flow cytometric results as prognostic factors in advanced ovarian carcinoma.
Kühn W; Kaufmann M; Feichter GE; Schmid H; Hanke J; Rummel HH
Eur J Gynaecol Oncol; 1988; 9(3):234-41. PubMed ID: 3391195
[TBL] [Abstract][Full Text] [Related]
53. Alterations in DNA methylation are early, but not initial, events in ovarian tumorigenesis.
Cheng P; Schmutte C; Cofer KF; Felix JC; Yu MC; Dubeau L
Br J Cancer; 1997; 75(3):396-402. PubMed ID: 9020485
[TBL] [Abstract][Full Text] [Related]
54. Nanobacteria promote crystallization of psammoma bodies in ovarian cancer.
Sedivy R; Battistutti WB
APMIS; 2003 Oct; 111(10):951-4. PubMed ID: 14616547
[TBL] [Abstract][Full Text] [Related]
55. DNA content of mucinous tumors of the ovary.
Weiss RR; Richart RM; Okagaki T; Cottral GA
Am J Obstet Gynecol; 1969 Feb; 103(3):409-24. PubMed ID: 5763126
[No Abstract] [Full Text] [Related]
56. Possibilities and progress of quantitative pathological examination of ovarian tumours.
Baak JP
Eur J Obstet Gynecol Reprod Biol; 1988 Nov; 29(3):183-9. PubMed ID: 2851466
[TBL] [Abstract][Full Text] [Related]
57. [DNA cytophotometry in pathology and surgery].
Dietel M
Langenbecks Arch Chir; 1992; 377(1):1-3. PubMed ID: 1569799
[No Abstract] [Full Text] [Related]
58. Prognostic importance of psammoma bodies in adenocarcinomas of the ovaries.
Sorbe B; Frankendal B
Gynecol Oncol; 1982 Aug; 14(1):6-14. PubMed ID: 7095589
[No Abstract] [Full Text] [Related]
59. [Analysis by flow cytometry and cell sorting. Report of current status and perspectives for pathology].
Knüchel R
Pathologe; 1994 Apr; 15(2):85-95. PubMed ID: 8197072
[TBL] [Abstract][Full Text] [Related]
60. Elevated CA125 in primary peritoneal serous psammocarcinoma: a case report and review of the literature.
Zhen-Zhong D; Zheng N; Liu H; Liao DY; Ye XQ; Zhou QM; Jie ; Li HH; Liu Q; Lu KM
BMJ Case Rep; 2009; 2009():. PubMed ID: 21686474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
